22 results
Thumbnail

D3.295 - Comparing Real-World and AI-Enabled Market Research in Caregivers of Individuals with Peanut Allergy

Thumbnail

D3.296 - Alpha-gal Syndrome with Concomitant Milk Sensitization in a Patient with Asthma and Allergic Rhinitis: A Case Report

Thumbnail

D3.297 - De-labelling peanut allergy in a 19-year-old woman with detectable Ara h 2 sensitization: a real-life, exercise-augmented oral food challenge

Thumbnail

D3.298 - The Good, the Bad and the Ugly : Mugwort, Mango, and Pineapple

Thumbnail

D3.300 - Wheat tolerance induction protocol

Thumbnail

D3.301 - Аллергия на белки коровьего молока у детей: сосредоточено на короткоцепочечных жирных кислотах

Thumbnail

D3.302 - Sesame as an under-recognized allergen: storage protein sensitization underlying food-induced anaphylaxis in a young adult

Thumbnail

D3.303 - Buckwheat Allergy in Bologna Metropolitan Area: Often Severe, Often Hidden

Thumbnail

D3.304 - Real-Life Evaluation of the Egg Ladder in a Tertiary Pediatric Allergy Center in Turkey

Thumbnail

D3.305 - Isolated IgE-Mediated Anaphylaxis to Pine Nut in an adult

Thumbnail

D3.440 - Long-Term Efficacy and Safety of Donidalorsen for Hereditary Angioedema Among Patients in Europe: A Regional Analysis of the OASISplus Study

Thumbnail

D3.441 - Switching to Donidalorsen for Hereditary Angioedema: 1-Year Results From the Phase 3 OASISplus Study

Thumbnail

D3.444 - Efficacy and Safety of Donidalorsen for Patients With Hereditary Angioedema in Europe Who Switched From Prior Long-Term Prophylaxis: Results From the OASISplus Study

Thumbnail

D3.445 - Validation of a Novel Serum-Based Indirect Basophil Activation Test (iBAT) to Evaluate Efficacy of a Pivotal Phase III PQ Grass Immunotherapy Trial

Thumbnail

D3.437 - Impact of benralizumab on fatigue and health-related quality of life in patients with hypereosinophilic syndrome: findings from the NATRON phase 3 trial

Thumbnail

D3.438 - Clinical outcomes with navenibart according to baseline attack rate, body mass index, and age: results of the ALPHA-STAR trial

Thumbnail

D3.439 - Donidalorsen For The Treatment Of Hereditary Angioedema: 1-Year Results From The OASISplus Open-Label Extension Cohort

Thumbnail

D3.442 - Patient-Reported Outcomes With Long-Term Donidalorsen Treatment Among Patients In Europe With Hereditary Angioedema: 1-Year Interim Results From The OASISplus Open-Label Extension Cohort

Thumbnail

D3.443 - Patient-Reported Outcomes With Long-Term Donidalorsen Treatment Among Patients In Europe With Hereditary Angioedema: 1-Year Interim Results From The OASISplus Switch Cohort

Thumbnail

D3.446 - PROTECT Phase I/IIa Clinical Trial Demonstrated Strong Correlation Between Humoral Immune Response and Dose of VLP Peanut in Healthy Participants